Express Pharma
Express Pharma
Browsing tag
dupilumab
Dupixent (dupilumab) gets DCGI approval to treat moderate-to-severe atopic dermatitis
Read more
US FDA accepts Dupixent for priority review in adults with prurigo nodularis
Read more
Pfizer’s phase-III Jade trial shows positive results
Read more